Your session is about to expire
← Back to Search
N-acetylcysteine for Autism
Study Summary
This trial will examine the effects of NAC on restricted and repetitive behaviors in children with autism, using a double-blind, placebo-controlled study. Results may help explain how NAC can reduce symptom severity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My child is between 3 and 12 years old.My medications and mental health treatments have been stable for over a month.My autism diagnosis was confirmed with standard assessments.I am currently taking glutathione or related medications.I cannot drink the study medication if it's mixed in a liquid.I have a genetic condition linked to autism.My physical development is at the earliest stage of puberty.
- Group 1: N-acetylcysteine
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the participant criteria for this trial open to individuals beyond age forty?
"This medical trial stipulates that participants must have a minimum age of 3 and must not exceed the age of 12."
Who can partake in this clinical trial?
"Applicants who meet the criteria of having autism and ranging in age from 3 to 12 may participate in this medical trial. Currently, 48 patients are being accepted as part of this study."
How many participants are included in this clinical research?
"Indeed, the information posted on clinicaltrials.gov confirms that this medical trial is actively recruiting participants. The investigation was first made public on February 1st 2023 and has since been updated as of September 2nd 2023. At present, 48 patients are being enrolled from a single site."
Is this experiment actively seeking participants at the moment?
"Confirmed. According to clinicaltrials.gov, this research project is still actively seeking participants and was first posted on February 1st 2023 with its most recent update coming on the 9th of that same month. The investigators are hoping to recruit 48 individuals from a single site."
Share this study with friends
Copy Link
Messenger